How to Pressure-Test Regulatory Support Before Market Entry

Start by naming what you actually need to validate

Most teams entering a new market conflate three different questions: whether the regulator will approve the application, whether senior supervisors are comfortable with the approach, and whether the political and policy environment will hold steady through authorisation. These need separate tests. A regulator can approve a filing while quietly disliking the model, and that quiet discomfort becomes the post-authorisation supervisory agenda you did not plan for.

Before you do any external work, write down the specific assumptions your board has implicitly signed off on. Not 'the regulator supports our approach' but 'the head of authorisations accepts our proposed governance structure', 'the relevant policy lead is not planning a consultation that would change the rules within 18 months', 'the prudential supervisor is comfortable with our capital model'. If you cannot write these as testable propositions, you are not ready to test them.

Map the decision chain, not the org chart

In most regulators, the named senior official is not the person whose view will decide your case. The case officer drafts the recommendation. A technical specialist signs off on the model. A policy team owns the rulebook interpretation. A supervisor inherits you after authorisation. Each has a different incentive structure and a different definition of a good outcome.

Work out which of these people has not yet been sounded out, directly or indirectly, on the specific elements of your approach. That gap is your validation priority. Senior sponsorship at the top of the regulator is necessary but rarely sufficient: the technical layer kills more applications than the executive layer does.

Use proxies before you use principals

Going direct to a regulator with 'do you support our approach' is the wrong move. It forces a defensive answer and burns a conversation you may need later. Instead, test through proxies first:

• Former regulators now in advisory roles, particularly those who left within the last two years and retain live relationships
• Trade body representatives who sit on regulatory working groups and hear the unfiltered version
• Counsel who have recently taken comparable applications through the same team
• Peer firms who have just authorised in adjacent products

The goal is not to triangulate a yes or no. It is to identify which specific elements of your approach will attract friction and from whom. If three independent proxies flag the same concern, treat it as fact.

Then go direct, but go narrow

Once you know where the friction sits, you can structure direct engagement around specific technical questions rather than broad endorsement. Pre-application meetings work best when you bring a defined problem and a proposed solution, not a pitch. Ask 'we are considering structure A or structure B for this control, here is our reasoning, what would concern you about each' rather than 'do you support our entry'.

Watch what they do not say. Regulators rarely tell you no in a meeting. They tell you no by asking the same question three different ways, by referencing recent enforcement, or by suggesting you 'think further' about a point. Train your team to log these signals as carefully as the explicit feedback.

What good validation looks like before the board commits

You should be able to tell your board, for each material assumption: who we tested it with, what they said, what they did not say, and what would have to change for our view to be wrong. If you cannot answer the last question, you have not pressure-tested anything, you have just gathered confirmation.

The most common failure is treating warm signals from senior contacts as validation of technical assumptions those contacts are not close to. A regulator's CEO endorsing your strategic intent tells you nothing about whether the authorisations team will accept your operational resilience framework.

The decision point

Before the board commits resources, force this question: what is the single assumption that, if wrong, would make this market entry uneconomic, and have we tested it with someone whose job it would be to challenge it? If the honest answer is no, delay the commitment by a quarter and run that test. The cost of a quarter is small. The cost of authorisation failure, or worse, conditional authorisation that constrains the business model, is not.